Medical Dermatology Therapy Online Series
Treatment of Psoriatic Disease
Release Date: July 20, 2022
Expiration Date: July 20, 2024
Estimated Time of Completion: 1 hour
Description
Participate in this CME-certified, on demand online education for a unique opportunity to update your knowledge and understanding of both traditional and new therapeutic strategies for a range of critically important medical dermatologic conditions, including rheumatology-dermatology overlap diseases, medical dermatologic diseases, psoriatic disease, and the interprofessional approach to patients on biologics.
Learning Objectives
- Describe updates in traditional treatment options, both skin-directed and systemic, for medical dermatologic diseases.
- Summarize updates in the pathogenesis of various medical dermatologic diseases and how this relates to both drug development and use of traditional and modern therapeutic options.
- Review the current knowledge of the impact of systemic treatment for moderate-to-severe psoriasis on future cardiovascular health.
Target Audience
This course is designed for physicians, pharmacists, nurses, advanced practice clinicians, physician assistants, residents, fellows and allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine, and general practice.
Accreditation
In support of improving patient care, this activity has been planned and implemented by Cleveland Clinic Center for Continuing Education. Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this live activity for a maximum of 1.0 ANCC contact hours.
Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
American Board of Internal Medicine (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Activity Director and Faculty
Activity Director
Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
W.D. Steck Chair of Clinical Dermatology
Departments of Dermatology and Pathology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH
Faculty
Andrew Blauvelt, MD, MBA
Oregon Medical Research Center
Portland, OR
Nehal Mehta, MD
National Institutes of Health
Bethesda, MD
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
Andrew Blauvelt, MD |
Abbvie Pharmaceuticals
Pfizer
UCB |
Consulting
Teaching and Speaking
Principal or Co-Investigator of funded research |
Anthony P Fernandez, MD |
Bristol-Myers Squibb Co. UCB, Inc. |
Consulting |
Corbus Pharmaceuticals Pfizer, Inc. |
Research / Independent Contractor |
Mallinckrodt Inc. Novartis |
Consulting Research / Independent Contractor Teaching and Speaking |
Abbvie Pharmaceuticals |
Consulting Research / Independent Contractor Advisor or review panel participant Teaching and Speaking |
Kyowa Kirin |
Teaching and Speaking |
The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:
Nehal Mehta, MD
Acknowledgment
The Cleveland Clinic Center for Continuing Education
acknowledges educational grants for partial support of this activity from:
Amgen, Inc.
ChemoCentryx
Janssen Scientific Affairs
Novartis Pharmaceuticals Corporation
This CME activity was produced by the Cleveland Clinic Center for Continuing Education and Cleveland Clinic Department of Dermatology.